LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000492.4:c.3718-2477C>T
CFTR
· NP_000483.3:p.?
· NM_000492.4
GRCh37: chr7:117280015 C>T
·
GRCh38: chr7:117639961 C>T
Gene:
CFTR
Transcript:
NM_000492.4
Final call
VUS
PS3 supporting
PM3 moderate
PP5 supporting
Variant details
Gene
CFTR
Transcript
NM_000492.4
Protein
NP_000483.3:p.?
gnomAD AF
0.00011841793637009553 (v4.1)
ClinVar
Pathogenic
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PS3 supporting: exact-variant RT-PCR demonstrated an aberrant 84-bp cryptic exon and reduced correctly spliced CFTR RNA.
2
PM3 moderate: an affected CF fetus carried the variant in trans with pathogenic F508del.
3
PP5 supporting: the CFTR2 ClinVar expert panel classified the exact variant as Pathogenic.
Final determination:
Under generic ACMG/AMP 2015 rules, 1 moderate plus 2 supporting pathogenic criteria does not satisfy a pathogenic or likely pathogenic combination, and no benign rule is satisfied; therefore the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.3718-2477C>T is a deep-intronic C>T SNV with NP_000483.3:p.?, not a canonical splice-site or other null variant named by PVS1. |
pvs1_variant_assessment
PMID:10351951
|
| PS1 | N/A | Not applicable: the deep-intronic variant has protein consequence p.? and creates an 84-bp cryptic exon rather than an amino-acid substitution. |
PMID:10351951
|
| PS2 | Not assessed | Not assessed: no documented de novo occurrence, confirmed maternity and paternity, or absence of family history is available for this patient. |
|
| PS3 | Met | Met at supporting strength: exact-variant RT-PCR found an 84-bp cryptic exon with an in-frame stop codon and normal CFTR RNA as low as 1% in ileum. |
PMID:10351951
|
| PS4 | Not met | Not met: no exact-variant case-control counts, odds ratio, relative risk, or confidence interval were verified against the PS4 threshold of OR/RR >5.0 with CI excluding 1.0. |
PMID:15371902
|
| PM1 | N/A | Not applicable: p.? provides no protein residue to place in a mutational hotspot or critical functional domain. |
PMID:10351951
|
| PM2 | Not met | Not met: gnomAD v4.1 grpmax FAF=0.00016885 exceeds the PM2 supporting cutoff of 0.0001, although the variant is rare. |
gnomad_v4
gnomad_v2
PMID:25741868
|
| PM3 | Met | Met: an affected CF fetus was compound heterozygous for c.3718-2477C>T and F508del, directly documenting the assessed variant in trans with a pathogenic allele. |
PMID:10351951
|
| PM4 | N/A | Not applicable: the variant is a deep-intronic C>T SNV with p.?, not an in-frame coding indel or stop-loss protein-length change. |
pvs1_variant_assessment
PMID:10351951
|
| PM5 | N/A | Not applicable: the splice variant has protein consequence p.? and no amino-acid residue for an alternate-missense comparison. |
PMID:10351951
|
| PM6 | Not assessed | Not assessed: no patient-specific evidence indicates that this variant was assumed de novo without confirmed maternity and paternity. |
|
| PP1 | Not assessed | Not assessed: no affected relatives, informative meioses, or variant genotypes across a family are documented to evaluate co-segregation. |
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, but this variant is deep intronic with protein consequence p.? and aberrant splicing. |
PMID:10351951
|
| PP3 | Not met | Not met: SpliceAI max delta 0.162 is below the generic PP3 supporting threshold of 0.2 for this intronic variant. |
spliceai
|
| PP4 | Not assessed | Not assessed: a sufficiently specific patient phenotype or family history supporting a single genetic etiology was not provided. |
|
| PP5 | Met | Met: ClinVar variation 7166 records the exact variant as Pathogenic by the CFTR2 expert panel, meeting the specified PP5 source requirement. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF=0.00016885 is below the BA1 threshold of 0.05, despite the Ashkenazi Jewish point estimate of 0.00172911. |
gnomad_v4
gnomad_v2
clinvar
PMID:25741868
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF=0.00016885 is below the generic BS1 default of 0.01 and does not show an unexpectedly high disorder allele frequency. |
gnomad_v4
clinvar
|
| BS2 | Not met | Not met: gnomAD v4.1 observed 0 homozygotes among 18 alleles, with no documented healthy adult homozygote for this autosomal-recessive CFTR variant. |
gnomad_v4
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no well-established benign functional study was identified, while the available exact-variant assay instead showed aberrant splicing and reduced normal CFTR RNA. |
|
| BS4 | Not assessed | Not assessed: no affected relatives without the variant or pedigree evidence addressing phenocopies and alternative pathogenic variants is documented. |
|
| BP1 | N/A | Not applicable: BP1 requires a missense variant, but this deep-intronic variant has protein consequence p.? and a splice mechanism. |
PMID:10351951
|
| BP2 | Not met | Not met: the observed compound heterozygosity is trans in recessive CFTR, while BP2 requires trans in a fully penetrant dominant disorder or cis in any inheritance pattern. |
PMID:10351951
|
| BP3 | N/A | Not applicable: c.3718-2477C>T is a deep-intronic C>T SNV, not an in-frame deletion or insertion in a repetitive region. |
pvs1_variant_assessment
PMID:10351951
|
| BP4 | Not met | Not met: SpliceAI max delta 0.162 exceeds the generic BP4 supporting threshold of 0.1 for this intronic variant. |
spliceai
|
| BP5 | Not assessed | Not assessed: no case-level alternate molecular diagnosis was documented for a patient carrying this variant. |
|
| BP6 | Not met | Not met: the exact-variant ClinVar expert-panel record is Pathogenic, with no Benign or Likely benign expert-panel assertion supporting BP6. |
clinvar
|
| BP7 | N/A | Not applicable: the variant is intronic, whereas BP7 applies only to synonymous variants with no predicted splice impact and low conservation. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.